Nurs 120 Exam #Questions With Correct
Answers
Absorption |- |CORRECT |ANSWER✔✔-process |by |which |drug |mlcs |cross |biological |membranes |&
|get |to |targeted |organ
The |rate |of |absorption |determines |- |CORRECT |ANSWER✔✔-when |drug |becomes |available |to
|exert |its |action
Absorption |also |influences |- |CORRECT |ANSWER✔✔-metabolism |& |excretion
Absorption |depends |on |- |CORRECT |ANSWER✔✔-1) |route |of |administration |
2) |form |of |drug
3) |drug |solubility
4) |effects |of |pH
5) |blood |flow |to |area
6) |body |surface |area
,Acute |therapy |- |CORRECT |ANSWER✔✔-Involves |intensive |drug |treatment |& |is |implemented |in
|acutely |ill |or |even |critically |ill |to |sustain |life |or |treat |disease
Acutely |ill |- |CORRECT |ANSWER✔✔-those |w |rapid |onset |of |illness
Adverse |reaction |- |CORRECT |ANSWER✔✔-unintended |& |undesirable |effect |produced |by |drug
Allergic |reaction |- |CORRECT |ANSWER✔✔-immunologic |hypersensitivity |reaction |resulting |from
|unusual |sensitivity |of |pt |to |a |particular |med
Allergic |reactions |range |from |- |CORRECT |ANSWER✔✔-minor |to |serious; |however, |even |small
|amount |of |med |can |cause |severe |reaction
Medications |most |frequently |implicated |in |allergic |reactions |- |CORRECT |ANSWER✔✔-
antibiotics, |biological |agents |& |diagnostic |agents
Alternative |medicine |- |CORRECT |ANSWER✔✔-therapies |used |instead |of |conventional |medicine
|& |whose |reliability |has |not |been |validated |through |clinical |testing |in |United |States
Chemical |name |- |CORRECT |ANSWER✔✔-describes |drug's |chemical |composition |& |molecular
|structure
2-(p-isobutylphenyl) |propionic |acid |- |CORRECT |ANSWER✔✔-chemical |name |for |ibuprofen
Compatibility |- |CORRECT |ANSWER✔✔-able |to |be |safely |mixed
,Contraindication |- |CORRECT |ANSWER✔✔-reason |something |is |not |advisable |or |should |not |be
|done
Dissolution |- |CORRECT |ANSWER✔✔-breaking |up |into |parts; |termination |of |legal |bond |or
|contract
Distribution |- |CORRECT |ANSWER✔✔-process |by |which |drug |reversibly |leaves |bloodstream |&
|enters |extracellular |fluid |and/or |cells |or |tissues |
[think |about |blood |brain |barrier |and |placental |barrier]
The |rate |of |distribution |is |influenced |by |- |CORRECT |ANSWER✔✔-1) |adequate |local |blood |flow
|in |target |area |
2) |permeability |of |capillaries |to |drug's |mlcs
3) |protein-binding |capacity |of |drug
target |area |- |CORRECT |ANSWER✔✔-site |where |drug |effects |occur
Excretion |- |CORRECT |ANSWER✔✔-elimination |of |drug |and/or |byproducts |from |body
Generic |name |aka |- |CORRECT |ANSWER✔✔-nonproprietary |name
Generic |name/nonproprietary |name |- |CORRECT |ANSWER✔✔-assigned |by |USAN |council |when
|developing |drug |is |ready |to |market |drug
, USAN |- |CORRECT |ANSWER✔✔-united |states |adopted |names |council
Generic/nonproprietary |name |is |usually |similar |to |- |CORRECT |ANSWER✔✔-chemical |name |but
|in |simpler |form
Half-life |- |CORRECT |ANSWER✔✔-amount |of |time |it |takes |for |half |of |drug |to |be |eliminated
Example: |
Tramadol |has |a |half-life |of |approximately |6 |hours. |This |means |if |you |take |a |50 |mg |dose |at
|0800, |- |CORRECT |ANSWER✔✔-by |1400, |half |of |that |dose |[25 |mg] |will |still |be |left |in |your
|body. |In |12 |hours, |1/4 |of |initial |dose |[12.5 |mg] |will |be |left |in |body
Half |life |is |affected |by |- |CORRECT |ANSWER✔✔-drug |composition |& |distribution
What |things |prolong |half |life? |- |CORRECT |ANSWER✔✔-1) |liver |& |kidney |disease
2) |aging
3) |absence |of |food
4) |slowed |metabolic |rate
Why |do |liver |and |kidney |disease, |aging, |absence |of |food |& |slowed |metabolic |rate |prolong |half
life? |- |CORRECT |ANSWER✔✔-bc |of |effects |on |metabolism |& |excretion
|
Herbal |medication |- |CORRECT |ANSWER✔✔-not |approved |for |use |as |drugs, |not |FDA |regulated
Answers
Absorption |- |CORRECT |ANSWER✔✔-process |by |which |drug |mlcs |cross |biological |membranes |&
|get |to |targeted |organ
The |rate |of |absorption |determines |- |CORRECT |ANSWER✔✔-when |drug |becomes |available |to
|exert |its |action
Absorption |also |influences |- |CORRECT |ANSWER✔✔-metabolism |& |excretion
Absorption |depends |on |- |CORRECT |ANSWER✔✔-1) |route |of |administration |
2) |form |of |drug
3) |drug |solubility
4) |effects |of |pH
5) |blood |flow |to |area
6) |body |surface |area
,Acute |therapy |- |CORRECT |ANSWER✔✔-Involves |intensive |drug |treatment |& |is |implemented |in
|acutely |ill |or |even |critically |ill |to |sustain |life |or |treat |disease
Acutely |ill |- |CORRECT |ANSWER✔✔-those |w |rapid |onset |of |illness
Adverse |reaction |- |CORRECT |ANSWER✔✔-unintended |& |undesirable |effect |produced |by |drug
Allergic |reaction |- |CORRECT |ANSWER✔✔-immunologic |hypersensitivity |reaction |resulting |from
|unusual |sensitivity |of |pt |to |a |particular |med
Allergic |reactions |range |from |- |CORRECT |ANSWER✔✔-minor |to |serious; |however, |even |small
|amount |of |med |can |cause |severe |reaction
Medications |most |frequently |implicated |in |allergic |reactions |- |CORRECT |ANSWER✔✔-
antibiotics, |biological |agents |& |diagnostic |agents
Alternative |medicine |- |CORRECT |ANSWER✔✔-therapies |used |instead |of |conventional |medicine
|& |whose |reliability |has |not |been |validated |through |clinical |testing |in |United |States
Chemical |name |- |CORRECT |ANSWER✔✔-describes |drug's |chemical |composition |& |molecular
|structure
2-(p-isobutylphenyl) |propionic |acid |- |CORRECT |ANSWER✔✔-chemical |name |for |ibuprofen
Compatibility |- |CORRECT |ANSWER✔✔-able |to |be |safely |mixed
,Contraindication |- |CORRECT |ANSWER✔✔-reason |something |is |not |advisable |or |should |not |be
|done
Dissolution |- |CORRECT |ANSWER✔✔-breaking |up |into |parts; |termination |of |legal |bond |or
|contract
Distribution |- |CORRECT |ANSWER✔✔-process |by |which |drug |reversibly |leaves |bloodstream |&
|enters |extracellular |fluid |and/or |cells |or |tissues |
[think |about |blood |brain |barrier |and |placental |barrier]
The |rate |of |distribution |is |influenced |by |- |CORRECT |ANSWER✔✔-1) |adequate |local |blood |flow
|in |target |area |
2) |permeability |of |capillaries |to |drug's |mlcs
3) |protein-binding |capacity |of |drug
target |area |- |CORRECT |ANSWER✔✔-site |where |drug |effects |occur
Excretion |- |CORRECT |ANSWER✔✔-elimination |of |drug |and/or |byproducts |from |body
Generic |name |aka |- |CORRECT |ANSWER✔✔-nonproprietary |name
Generic |name/nonproprietary |name |- |CORRECT |ANSWER✔✔-assigned |by |USAN |council |when
|developing |drug |is |ready |to |market |drug
, USAN |- |CORRECT |ANSWER✔✔-united |states |adopted |names |council
Generic/nonproprietary |name |is |usually |similar |to |- |CORRECT |ANSWER✔✔-chemical |name |but
|in |simpler |form
Half-life |- |CORRECT |ANSWER✔✔-amount |of |time |it |takes |for |half |of |drug |to |be |eliminated
Example: |
Tramadol |has |a |half-life |of |approximately |6 |hours. |This |means |if |you |take |a |50 |mg |dose |at
|0800, |- |CORRECT |ANSWER✔✔-by |1400, |half |of |that |dose |[25 |mg] |will |still |be |left |in |your
|body. |In |12 |hours, |1/4 |of |initial |dose |[12.5 |mg] |will |be |left |in |body
Half |life |is |affected |by |- |CORRECT |ANSWER✔✔-drug |composition |& |distribution
What |things |prolong |half |life? |- |CORRECT |ANSWER✔✔-1) |liver |& |kidney |disease
2) |aging
3) |absence |of |food
4) |slowed |metabolic |rate
Why |do |liver |and |kidney |disease, |aging, |absence |of |food |& |slowed |metabolic |rate |prolong |half
life? |- |CORRECT |ANSWER✔✔-bc |of |effects |on |metabolism |& |excretion
|
Herbal |medication |- |CORRECT |ANSWER✔✔-not |approved |for |use |as |drugs, |not |FDA |regulated
